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ABSTRACT 
Objective The aim of this systematic review was to synthesize data from randomized con­
trolled trials (RCTs) investigating the effects of oolong tea on postprandial triglyceride (TG) 
levels. 
Methods A literature search was performed using the electronic databases of PubMed, 
Cochrane Library, EMBASE, Ichushi-Web (Japan), JDreantlll (Japan), and Thai-Journal 
Citation Index (TCI) search (Thailand). We detected 233 related literature articles in the 
databases. Of these, two studies fulfilled the eligibility criteria of our study. 
Results A total of 50 participants from the two studies fufilled the selection criteria, and the 
interventions of both studies were oolong tea rich in oolong tea polymerized polyphenols 
(OTPP). OTPP dosage ranged from approximately 70 mg and resulted in a significantly 
more pronounced decrease in postprandial TG levels at the 4th hour after a high-fat meal 
intervention (mean di仔erence (MD): -18.87 mg/dL, (95% confidence interval (CJ) -22.92 
to-14.82), P<0.00001, /2= 0%, n = 2 trials) and also at the 5th hour after a high-fat inter­
vention (MD: - I 2.24 mg/dL, (95% CI-l 6.47 to-8.0 I), P<0.00001, /2= 0%, n = 2 trials) 
as compared with controls, respectively. 
Conclusion The current systematic review provides some evidence that oolong tea, espe­
cially OTTP-enriched oolong tea, may have a beneficial effect on postprandial serum TG 
levels. However, the data are limited and the included trials had methodological limitations. 
Results from large, rigorously designed RCTs are needed to assess the effect of oolong tea 
consumption on postprandial serum TG levels. 
(Jpn Pharmacol Ther 2018 ; 46 : 1339-46) 
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INTRODUCTION 
Over recent decades, there have been large changes in 
modern lifestyles, and both nutrition habits and physi­
cal inactivity have adversely affected public health. 
Obesity, diabetes, and metabolic syndrome are now 
relatively common. One outstanding result is the pro­
longed and exaggerated state of postprandial hyperlip­
idemia due to the ingestion of multiple fat-rich meals 
during the day. Fats ingested from meals, etc., are 
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Fig. 1 Flow diagram of the study search and selection process 
ln the primary screening, the relevancy of the publications was assessed based on the title and abstract. In the secondary screening 
the studies were evaluated based on the main text. 
micellized by the lipase secreted from the pancreas 
into the gastrointestinal tract and absorbed in the small 
intestine. This is then transported into the body as 
lipoprotein and stored as subcutaneous fat and visceral 
fat. The accumulation of excess fat, subcutaneous and 
visceral, leads to obesityりPostprandial (non-fasting) 
hyperlipidemia refers to a condition in which the 
blood levels of exogenous triglyceride (TG) are ele­
vated. This is a risk factor for cardiovascular disease 
(CVD), such as atherosclerosis. 2-9) As such, it is 
important to decrease serum TG levels under not only 
fasting conditions, but also non-fasting (postprandial) 
conditions. 
Tea is one of the most popular beverages in Asia 
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and is traditionally considered to have a healthy effect. 
Recently, the ingredients that make up tea have been a 
focus of interest. Tea is an extract obtained from 
Camellia sinensis L. leaves and is roughly classified 
into three types: the first is green tea, which is nonfer­
mented; second is black tea, which is fermented; and 
third is oolong tea, which is semi-fermented.1) Along 
with the characteristic scent produced by both the 
enzymatic and thermal reactions of tea leaves, polym­
erized polyphenols are produced from catechins 
through various polymerization processes. These 
polymerized polyphenols inhibit pancreatic lipase 
activity, which plays an important role in the fat 
absorption process.10l The structure activity relation-
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ship of polyphenols contained in oolong tea for lipase 
inhibition has been investigated. The activity of a 
dimer (oolonghomobisflavan) was higher than that of 
a monomer [ (-)-Epigal locatechin 3-0-gal late 
(EGCG)]; when the catechin gal late ester was enzy­
matically degraded, the inhibitory activity decreased. 
These results suggest that lipase inhibition requires 
polymerization and the presence of gallate ester 
groups. Whereby many polymerized polyphenols with 
gallate ester groups are present in oolong tea, the 
lipase inhibitory action is thought to be useful.1) 
Therefore, we focused on evaluating the relationship 
between oolong tea and postprandial blood TG. In this 
study, we systematically reviewed the relationship 
between oolong tea and postprandial blood TG in 
healthy humans from the standpoint of preventing 
negative health effects caused by an excess intake of 
fat from meals. 
METHODS 
This study was designed according to the Preferred 
Reporting Items for Systematic Reviews and Meta­
Analyses (PRISMA) guidelines. This review protocol 
was designed by an experienced information specialist 
and reviewed by two corresponding authors (the pro­
tocol has not been registered). 
1 Literature review 
Articles were extracted using the electronic databases 
for PubMed (1946-June 2017), Cochrane Library 
(thru June 2017), EMBASE (thru June 2017), 
Ichushi-Web (1977-June 2017), JDreamIII (JSTPlus: 
1981-June 2017, JMEDPlus: 198 1-June 2017, 
JST7580: 1975-1981), and TC] search (2014-June 
2017). The following keywords were used: "oolong 
tea" and ("triglyceride" or "triglycerides" or "triglyc-
,, ヽヽ ・ ,, " ,, " 
erol or tnglycerols or triacylgycerol or triac-
cerols . References of the included studies were ylgly ") 
also scanned for potentially relevant articles. No 
restrictions were placed on the publication language. 
2 Study selection 
The following inclusion criteria were defined prior to 
the study selection process: 
(I) Participants: healthy adult males and females
including those with mild hypertriglyceride­
mia (fasting serum TG levels from 150 to
250 mg/dL).
(2) Intervention: oolong tea intake simultaneous
with meals
(3) Comparison: placebo intake
(4) Outcome: postprandial serum TG levels
(5) Study design: RCT, quasi-RCT, non-RCT,
and crossover.
Two reviewers independently assessed the titles 
and abstracts of all the reports identified by the elec­
tronic and manual searches. Subsequently, the full text 
of potential articles that met the inclusion criteria were 
screened, and a final decision was made. Disagree­
ment was resolved by consulting an additional 
reviewer. 
3 Risk of bias assessment 
The Cochrane collaboration tool for assessing risk of 
bias was used to elucidate the risk of bias of the 
included studies, attaching either low (green), uncle釘
(yellow), or high (red) risk of bias to seven domains 
(random sequence generation, allocation concealment, 
blinding of participants and personnel, blinding of out­
come assessment, incomplete outcome data, selective 
reporting, and other bias) for each study.11) 
4 Data extraction and analyses 
Data extracted from each trial were: reference, sample 
size, male/female (n/ n), age [years, mean土SD], BMI 
(mean士SD), duration (hours), design, diseases/ 
health status/medication, high-fat intervention, 
oolong tea intervention, comparison group, outcome 
parameter and adverse effects. Any relevant missing 
information on the trial was sought from the original 
author(s) of the article, if required. Our two reviewers 
independently extracted the data from each full-text 
report using a standard data extraction form. 
Two reports were extracted and integrated after 
examining whether they could be integrated without 
heterogeneity. All data were analyzed using Review 
Manager ver. 5.3 as provided by the Cochrane collab-
12) oration. The random effect model was used in con-
sideration of individual research variability. Using the 
random effects model, we compared the post-mean 
values or the changes from baseline values and corre­
sponding SD of the intervention and control/interven­
tion groups. Pooled effects of the different interven­
tions were investigated as MD. Heterogeneity between 
trial results was tested using a standard元test. The /2 
parameter was used to quantify any inconsistency: /2 
= ((Q-dj)) IQ X 100%, where Q is the 2 X statistic and 
df is its degree pf freedom. An /2-value>50% was 
considered to represent considerable heterogeneity. 
Dichotomous variables were analyzed, assessed and 
indicated along with P values and 95% confidence 
1341 
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intervals (Cis). We planned to use a test for asymme­
try of the funnel plot previously proposed.13) however, 
publication bias was not formally assessed using a 
funnel plot due to the small number of studies (< 10) 
included in the analyses.14) If appropriate, a meta­
analysis was conducted. The data were analyzed using 
Review Manager ver. 5.3. 
RESULTS 
1 Literature search and study characteristics 
We initially gathered 233 literature articles from the 
databases. Of the 233 articles, 26 were selected based 
on the primary (title and abstract) screening. Subse­
quently, 26 articles were screened in the secondary 
(full text) screening. Finally, five studies that fit the 
eligibility criteria were extracted. Of these, three stud­
ies were excluded as duplicates, and two remaining 
studies with a total of 50 participants fulfilled the 
selection criteria of our study.15·16) Fig 1. sumn1arizes 
the steps involved in the selection process. 
We examined risk of bias in each paper and did 
not find any domains whose risk of bias was high 
(red). Almost all domains showed a low (green) risk 
of bias risk. although some domains were rated as 
having some risk of bias (yellow) because various 
aspects were unclear. In total, both studies were 
assessed as having an "overall low risk of bias". The 
result of the risk of bias for each domain in both stud­
ies is summarized in Fig. 2. 
Considering clinical and methodological hetero­
geneity, it was reasonable to do a meta-analysis. We 
conducted meta-analyses for outcome at the 4th and 
5th hour after consumption of a high-fat meal. This 
time period was chosen because serum TG peaks at 
between 4 to 5 hours after having a meal. Study char­
acteristics are sumn1arized in Table 1. There was no 
missing data in the included studies. 
2 Postprandial serum triglyceride 
Hara Y, et al. reported that postprandial serum TG ele­
vation was significantly suppressed at the 3rd and 5th 
hours after ingestion of a high-fat meal by drinking an 
OTPP-enriched oolong tea beverage compared with 
the placebo beverage (P< 0.05). Also, the area under 
the curve of the serum TG level was significantly 
decreased (P< 0.05). Bumrungpert A, et al. indicated 
that postprandial serum TG elevation was significantly 
inhibited at the 2nd, 3rd, 4th, and 5th hours compared 
with the placebo beverage (P<0.001). Also, the 
oolong tea significantly decreased the area under the 
1342 
curve of the serum TG level (P< 0.00 I). The meta­
analysis showed that there was no problem in statisti­
cal heterogeneity. At the 4th hour after a high-fat meal 
consumption, oolong tea interventions resulted in a 
significant decrease in serum TG (MD: -18.87 mg/ 
dL, (95%CI: -22.92 to -14.82), P<0.00001, P= 
0%) as compared with the respective controls (Fig. 
3). A similar result was obtained from the data at the 
5th hour (MD: -12.14 mg/dL, (95% CI: -16.47 to 
-8.01), P<0.00001, /2 =0%) (Fig. 4).
3 Adverse effects 
Both RCTs reported on adverse effects. No adverse 
effect was found in one RCT.15) The severity of symp­
toms was reported in the other RCT, however, there 
were no significant differences in any of the observed 
symptoms between the intervention group and placebo 
group. 16)
DISCUSSION 
Our meta-analysis clearly demonstrated that oolong 
tea reinforced with OTPP, approximately 70 mg, sup­
presses the elevation of TG in blood after a high-fat 
meal intake in healthy adult males and females, 
including those with mild hyperlipidemia. In addition, 
the effect of suppressing TG elevation in postprandial 
blood by OTPP-enriched oolong tea was seen at 4-5 
hours when the postprandial TG showed a maximum 
value. 
All clinical trials considered in the eligibility cri­
teria utilized OTPP-enriched oolong tea. OTPP is a 
group of polyphenols specific to oolong tea wherein 
catechin is polymerized in the process of semi-fer­
mentation. Nakai, et al. found that OTPP could inter­
fere with fat absorption via inhibition of lipase activity 
in vitro. 1) In addition, Han, et al. reported that oolong 
tea prevents obesity in a high-fat diet by inhibiting the 
lipase activity of the pancreas in mice.17) Furthermore, 
Toyoda-Ono, et al. reported inhibitory effects of 
OTPP on postprandial TG after a high-fat diet load in 
mice and rats.18) Nakai, et al. showed that OTPP sup­
pressed both serum TG elevation and lymphatic TG 
absorption under a high-fat dietary condition in mice 
and rats.10) Furthermore, Hsu, et al. showed that poly­
phenol-enriched oolong tea increases lipid excretion 
into feces when ingesting a high-fat diet in healthy 
humans. 19) 
As described above, OTPP inhibits pancreatic 
lipase, suppresses the absorption of lipids in the gas­
trointestinal tract, and is excreted in feces, which is 
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Fig. 2 Risk of bias summary 
For each study, every bias domain was evaluated. Review 
author judgements about each risk of bias item are for each 
included study. Green means low risk, yellow means unclear 
risk and red means high risk. 
thought to suppress postprandial serum TG elevation. 
Our systematic review and meta-analysis results sug­
gested that OTPP-enriched oolong tea suppressed a 
postprandial TG increase in humans, which did not 
contradict previously reported results. 
In recent years, it is becoming clear that the rise 
in blood TG after a meal (not fasting), rather than fast­
ing TG is a risk factor of CVD, especially for arterio­
sclerosis. The need to suppress the blood TG value 
under not only a fasting condition, but also a non-fast­
ing (postprandial) condition has been considered. The 
results of our systematic review and meta-analysis 
suggested that OTPP-enriched oolong tea suppressed 
the elevation of postprandial TG in humans, which 
may lead to a reduced risk of CVD such as arterio­
sclerosis. 
Excessive fat ingestion from meals, etc., are 
absorbed and stored as subcutaneous fat and visceral 
fat. The accumulation of excessive fat results in obe­
sity. Various products have been developed to prevent 
weight gain, such as Orlistat. Orlistat is an agent that 
inhibits pancreatic lipase like OTPP and is used as an 
anti-obesity agent. Orlistat is a medicine that inhibits 
pancreatic lipase, thereby suppressing the absorption 
of fat contained in a meal from the gastrointestinal 
tract and provides a weight reduction effect. However, 
side effects including fatty stools, increased number of 
defecations, loose stools, etc., have been reported in 
Orlistat.20l Although the mechanism of OTPP is simi­
Jar to Orlistat, such side effects are not observed in 
oolong tea that includes OTPP. Therefore, OTPP­
enriched oolong tea may be considered as a beneficial 
and safe alternative that can be taken with every meal 
to suppress the absorption of fat. 
A population-based case-control study to evalu­
ate the association between consumption of tea, espe­
cially oolong tea, and risk of dyslipidemia was con­
ducted in Shantou, China, from 2010 to 2011.21> The 
study indicated that in the population who had taken 
oolong tea for a long period, lipid related items such 
as blood TG were lower and suggested that this may 
be related to the risk reduction for dyslipidemia. In 
this meta-analysis, we focused on the effects of single 
oolong tea ingestion on postprandial blood TG in 
1343 
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Table 1 Characteristics of randomized controlled trials included in the systematic review 
Reference 
Hara Y, et al 
2004 
Sample Size, Age BMI Duration Diseases/ 
Male/Female (years, (kg/m2 , (hours), Health Status/ 
(11/11) Mean士SD) Mean土SD) Design Medication 
22 (12/10) 49.7土8.9 25.9士3.8
Borderline to mild 
5 ヽ
hypertriglyceridemia 
Crossover 
(TG 100-250 mg/dL) 
High-fat 
Intervention 
Oolong Tea 
Intervention 
Fat enriched OTPP enriched 
corn soup oolong tea 
(containing 40 g (OTPP 
of fat, 434 kcal) 277.1µg/mL) 
Bumrungpert  
5 
Borderline to mild Corn soup Oolong tea 
36.5士Il .31 25.79土4.40 ' hypertriglyceridemia (containing 40 g (OTPP A, Chongsuwat 30 (15/15) 
R. 2015
Crossover 
(TG I 00-250 mg/dL) of fat) l 40µg/mL) 
Study or Subgroup 
Hara 2004 
Oolong tea 
Mean SD 
69 43.83 
Bumrungpert 2015 65.5 6.79 
Total 
20 
Placebo 
Mean SD 
90.7 61.72 
30 84.33 9.16 
Total (95% Cl) 50 
Heterogeneity: Tau2=0.00; Chi2=0.03, df=1 (P=0.87) ; /2=0% 
Test for overall effect : Z=9.13 (P<0.00001) 
Mean Difference 
Total Weight IV, Random, 95°/c。 Cl Year 
20 15% -21.70[-54 87, 11.47] 2004 
30 98.5°/4。 -1883[-22 91, -14.75] 2015 
50 100.0°/c。 -1887[-22 92, -14.82] 
Fig. 3 Effects of oolong tea on postprandial serum TG levels (mg/dL) at the 4th hour after a high-fat meal intake 
Forest plot showing pooled MD with 95% CI for two RCTs. For each study, the shaded square represents the point estimate of 
the intervention effect. The horizontal line joins the lower and upper limits of the 95% CI of these effects. The shaded square 
area reflects the relative weight of the study in the respective meta-analysis. The diamond at the bottom of the graph represents 
the pooled MD with the 95% CI for all study groups 
Oolong tea Placebo Mean Difference 
Study or Subgroup Mean SD Total Mean SD Total Weight IV, Random, 95% Cl Year 
Hara 2004 56.5 44.27 
8.13 
20 73.9 39.80 20 26% -1740 [-43.49, 8.69] 2004 
Bumrungpert 2015 59.03 30 71.13 8.79 30 97.4% -1210(-16.38, -782] 2015 
Total (95% Cl) 50 
Heterogeneity :Tau2=0.00; Chi2=0.15, df=1 (P=0.69) ; 12=0% 
Test for overall effect : Z=5.67 (P<0.00001) 
50 100.0% -12.24 [-16 47, -8.01) 
Fig. 4 Effects of oolong tea on postprandial serum TG levels (mg/dL) at the 5th hour after a high-fat meal intake 
Forest plot showing pooled MD with 95% CI for two RCTs. For each study, the shaded square represents the point estimate of 
the intervention effect. The horizontal line joins the lower and upper limits of the 95% Cl of these effects. The shaded square 
area reflects the relative weight of the study in the respective meta-analysis. The diamond at the bottom of the graph represents 
the pooled MD with the 95% CI for all study groups 
healthy subjects, so long-term effects are unknown. 
However, the ingestion of OTPP-emiched oolong tea 
with every meal leads to a suppression in the elevation 
of postprandial TG, and thus may contribute to the 
prevention of negative heal th effects induced by 
excess fat intake during meals. 
Generally, a systematic review has some major 
limitations. When the sample size of each RCT is 
small, by integrating multiple RCTs into meta-analy­
sis, the sample size increases and a higher level of 
1344 
evidence can be provided. However, in this review, 
there were only two studies satisfying the eligibility 
criteria, and thus the total sample size was still small 
after integration, and the possibility of publication bias 
could not be denied. Additionally, although there were 
no problems with heterogeneity, it is understood that 
when making a generalization, the number of subjects 
was small. Therefore, further research with larger 
sample sizes is necessary. 
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levels. 
Comparison Outcome Adverse 
Group Parameter effects 
Control 
beverage Serum No Advese 
(OTPP tnglycende effects 
33.7µg/n止）
Placebo dnnk 
No s1g111ficant 
(OTPP 
Serum difference 
0 /mL) 
tnglycende between oolong 
µg tea and placebo 
I 
-100
Mean Difference 
IV, Random, 95% Cl 
� 
-50 0 50 
Favours Oolong tea Favours Placebo 
I 
-100 
Mean Difference 
IV, Random, 95% Cl 3� 
I 
-50 0 50 
Favours Oolong tea Favours Placebo 
CONCLUSIONS 
I 
100 
I 
100 
The current systematic review provides some evidence 
that oolong tea, especially OTPP-enriched oolong tea, 
ranging from 68 mg to 70 mg, may have a beneficial 
and safe effect on postprandial serum TG levels. How­
ever, the data are limited and the included trials had 
methodological limitations. Results from large, rigor­
ously designed RCTs are needed to assess the effect of 
oolong tea consumption on postprandial serum TG 
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